Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

4 clinical studies listed.

Filters:

Venous Reflux

Tundra lists 4 Venous Reflux clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

ACTIVE NOT RECRUITING

NCT05504070

Venclose digiRF System Post Market Study

A Post-Market, Multi-Center, Prospective, Interventional Study for Treatment of Chronic Venous Disease of the Great and Small Saphenous Veins and Incompetent Perforator Veins.

Gender: All

Ages: 18 Years - Any

Updated: 2026-03-18

7 states

Venous Reflux
Chronic Venous Insufficiency
ACTIVE NOT RECRUITING

NCT03250247

Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy (The C-TRACT Trial)

The purpose of this study is to determine if the use of image-guided, endovascular therapy (EVT) is an effective strategy with which to reduce Post Thrombotic Syndrome (PTS) disease severity and improve quality of life in patients with established disabling iliac-obstructive post thrombotic syndrome (DIO-PTS).

Gender: All

Ages: 18 Years - Any

Updated: 2026-01-28

18 states

Deep Vein Thrombosis
Venous Stasis
Venous Insufficiency
+3
RECRUITING

NCT06811909

Non-healing Venous Leg Ulcers Treated With Standard Care With or Without BR-AC

This study examines a patient population with a non-healing, non-infected venous leg ulcer (VLU) having adequate arterial perfusion with confirmed venous reflux. It is hypothesized that weekly applications of the human placental allograft BioREtain® Amnion Chorion (BR-AC) applied to a non-healing VLU will result in a higher proportion of wounds showing complete healing within 12 weeks of initiating therapy, compared to standard care alone. This study has a crossover period, where subjects on standard care alone who do not achieve complete healing within 12 weeks of initiating therapy will be allowed to crossover to receive BR-AC over 12 additional weeks, to evaluate if their wound can achieve complete healing.

Gender: All

Ages: 18 Years - Any

Updated: 2026-01-23

8 states

Non-infected Venous Leg Ulcer
Venous Leg Ulcer
Venous Insufficiency
+2
NOT YET RECRUITING

NCT04774939

EVLA and Optimal Timing of Sclerotherapy

The aim of the study is to investigate the optimal timing of sclerotherapy for treatment of varicose tributaries on EVLA (endogenous laser ablation) patients.

Gender: All

Ages: 18 Years - 99 Years

Updated: 2021-03-01

Venous Reflux